The Microvascular Imaging Super Resolution Contrast-Enhanced Ultrasound application reportedly leverages micro-bubble contrast media to provide enhanced spatial resolution for imaging of malignant lesions.
Providing an alternative to the use of IV iodinated contrast media for assessing blood flow to and from malignant lesions, Philips has launched the Microvascular Imaging Super Resolution Contrast-Enhanced Ultrasound (CEUS) application, which was recently showcased at the International Bubble Conference in Chicago.
Recognizing that iodinated contrast media can lead to tolerability issues for some patients, Philips noted the new CEUS application, available on the Philips EPIQ Elite ultrasound device, utilizes micro-bubble contrast media derived from an inert gas excreted during breathing. The technology offers significantly improved spatial resolution, according to Philips.
Dirk-André Clevert, M.D, said the microvascular imaging capabilities of the new CEUS application elevate clinician assessment of lesions.
“Philips’ microvascular imaging allows us to visualize the pattern of contrast media flow into a lesion, and also shows how it changes over time, which gives us greater diagnostic confidence in assessing indeterminate lesions,” said Dr. Clevert, a professor of radiology at Ludwig-Maximilians-Universität (LMU) in Munich, Germany.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.